CytomX Therapeutics Inc. – Filings and Transcripts

NASDAQ: CTMX
Share price (5/22/26): $3.76
Market cap (5/22/26): $819 million

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

ended 03/31/26 Q1

ended 12/31/25 FY 2025

ended 09/30/25 Q3

ended 06/30/25 Q2

ended 03/31/25 Q1

Prospectuses and Registrations Filter

Prospectus supplement for primary offering

Prospectus supplement for primary offering

Automatic shelf registration

Registration of securities for employees

Shelf registration

Ownership Filter

Kynam Capital Management, LP

Venrock Healthcare Capital Partners III, L.P.

Longitude Capital Partners V, LLC

Perceptive Advisors LLC

Seven Fleet Capital Management LP

News Filter

Announces Q1 2026 Financial Results and Provides Business Update

Other Events, Financial Statements or Exhibits

Announces 2025 Financial Results and Provides Business Update

Announces Third Quarter 2025 Financial Results and Provides Business Update

Proxies Filter

Additional info about upcoming vote

Definitive proxy

Preliminary proxy

Additional info about upcoming vote

Definitive proxy

Other Filter

Notice of effectiveness

Correspondence with the SEC

Letter from the SEC

Notice of effectiveness

Correspondence with the SEC